Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of monitoring the efficacy of the anti-clever-1 therapy in cancer

Method of monitoring the efficacy of the anti-clever-1 therapy in cancer

US Patent 10884000 · Granted Jan 5, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized anti clever-1 antibodies and their use2025
Humanized anti clever-1 antibodies and their use2025
Method for determining patient's responsiveness to type 1 interferon treatment a2022
Humanized anti clever-1 antibodies and their use2021
Humanized anti clever-1 antibodies and their use2021
Cell and therapeutical and diagnostical methods based thereon2020
Lyophilised pharmaceutical formulation and its use2019
Lyophilised pharmaceutical formulation and its use2019
Method for determining acute respiratory distress syndrome (ARDS) related biomar2019
Method for determining acute respiratory distress syndrome (ARDS) related biomar2019
Isoform specific anti-HER4 antibodies2018
Biomarker for monitoring development of diseases and assessing the efficacy of t2015